Thomas G. Todaro

1.8k citations

29 papers · 1.3k indexed · h-index 16

Cardiology and Cardiovascular Medicine top 2%
Surgery top 10%
Immunology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Pathology and Forensic Medicine top 10%

Co-authors: Paul W. Armstrong Christopher B. Granger Kenneth W. Mahaffey Pierre Théroux Thomas G. Filloon W. Douglas Weaver Judith S. Hochman José Carlos Nicolau
Topics: Acute Myocardial Infarction Research (13 papers)Cardiac electrophysiology and arrhythmias (10 papers)Mechanical Circulatory Support Devices (9 papers)
Cited by: Cardiology and Cardiovascular Medicine Immunology Emergency Medicine
Journals: JAMA Circulation Journal of the American College of Cardiology
Partner nations: United States Canada United Kingdom

In The Last Decade

Thomas G. Todaro

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Thomas G. Todaro

Since Specialization

Citations

This map shows the geographic impact of Thomas G. Todaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Todaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Todaro more than expected).

Fields of papers citing papers by Thomas G. Todaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Todaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Todaro. The network helps show where Thomas G. Todaro may publish in the future.

Co-authorship network of co-authors of Thomas G. Todaro

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Todaro. A scholar is included among the top collaborators of Thomas G. Todaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Todaro. Thomas G. Todaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium 2017 ·American Heart Journal ·Salim F. Idriss,Stuart Berger,Kimberly G. Harmon,(unknown),Robert Kleiman,Martha Lopez-Anderson,Silvana Molossi,(unknown),(unknown),Thomas G. Todaro,Kaori Shinagawa,(unknown),Mitchell W. Krucoff,Victoria L. Vetter,Theressa J. Wright	6
2	Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors 2016 ·Cancer Chemotherapy and Pharmacology ·Johanna C. Bendell,Manish R. Patel,Ken‐Ichiro Yoshida,(unknown),(unknown),Charlotte Lemech,Thomas G. Todaro,Shubham Pant,Hendrik‐Tobias Arkenau	12
3	Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms 2015 ·Therapeutic Innovation & Regulatory Science ·(unknown),John K. Finkle,(unknown),Norman Stockbridge,(unknown),Kaori Shinagawa,Kenneth W. Mahaffey,James E. Tcheng,Daniel J. Lenihan,Chiara Melloni,Thomas G. Todaro,Eric L. Michelson,(unknown),Judith Zander,Richard Oh	1
4	Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes 2014 ·Therapeutic Innovation & Regulatory Science ·Mary Jane Geiger,Cyrus R. Mehta,J. Rick Turner,(unknown),Stefan Hantel,Boaz Hirshberg,Joerg Koglin,Boaz Mendzelevski,Philip T. Sager,Deborah R. Shapiro,Murray Stewart,Thomas G. Todaro,Brenda Gaydos	14
5	Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction 2012 ·Coronary Artery Disease ·(unknown),Kenneth W. Mahaffey,Yuliya Lokhnygina,José Carlos Nicolau,Witold Rużyłło,Peter X. Adams,Thomas G. Todaro,Paul W. Armstrong,Christopher B. Granger	4
6	Resolution of ST-segment depression: a new prognostic marker in ST-segment elevation myocardial infarction 2009 ·European Heart Journal ·Michael C. Tjandrawidjaja,Ya–Yuan Fu,Cynthia M. Westerhout,H. D. White,Thomas G. Todaro,Frans Van de Werf,K. W. Mahaffey,Galen S. Wagner,Christopher B. Granger,Paul W. Armstrong,(unknown)	23
7	Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial 2009 ·American Heart Journal ·Sorin J. Brener,Cynthia M. Westerhout,Yuling Fu,Thomas G. Todaro,David J. Moliterno,Galen S. Wagner,Christopher B. Granger,Paul W. Armstrong	7
8	Baseline Q-Wave Surpasses Time From Symptom Onset as a Prognostic Marker in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention 2009 ·Journal of the American College of Cardiology ·Paul W. Armstrong,Yuling Fu,Cynthia M. Westerhout,Michael Hudson,Kenneth W. Mahaffey,Harvey D. White,Thomas G. Todaro,Peter X. Adams,Philip E. Aylward,Christopher B. Granger	53
9	Integrating ancillary studies in a large clinical trial: The design and rationale of the APEX library 2008 ·Contemporary Clinical Trials ·Kenneth W. Mahaffey,Craig J. Reist,Yuling Fu,Sorin J. Brener,Pierre Théroux,Manesh R. Patel,Amanda Stebbins,Cynthia M. Westerhout,Thomas G. Todaro,Peter X. Adams,Christopher B. Granger,Paul W. Armstrong	8
10	Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI 2007 ·European Heart Journal ·Michael C. Tjandrawidjaja,Ya–Yuan Fu,Hussein R. Al‐Khalidi,Thomas G. Todaro,Philip C. Adams,Frans Van de Werf,Christopher B. Granger,Paul W. Armstrong,(unknown)	7
11	Assessment of pexelizumab in acute myocardial infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention 2006 ·Circulation ·Paul W. Armstrong,Peter X. Adams,Christian W. Hamm,William W. O’Neill,Alec Vahanian,Christopher B. Granger,David R. Holmes,Thomas G. Todaro,Frans Van de Werf	3
12	Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction 2006 ·American Heart Journal ·Paul W. Armstrong,Kenneth W. Mahaffey,Wei-Ching Chang,W. Douglas Weaver,Judith S. Hochman,Pierre Théroux,Scott A. Rollins,Thomas G. Todaro,Christopher B. Granger	15
13	Effect of Pexelizumab in Coronary Artery Bypass Graft Surgery With Extended Aortic Cross-Clamp Time 2006 ·The Annals of Thoracic Surgery ·Peter K. Smith,Michel Carrier,John C. Chen,Axel Haverich,Jerrold H. Levy,Philippe Menasché,Stanton K. Shernan,Frans Van de Werf,Peter X. Adams,Thomas G. Todaro,Edward D. Verrier	28
14	Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients 2006 ·The Annals of Thoracic Surgery ·Axel Haverich,Stanton K. Shernan,Jerrold H. Levy,John C. Chen,Michel Carrier,Kenneth M. Taylor,Frans Van de Werf,Mark F. Newman,Peter X. Adams,Thomas G. Todaro,(unknown),Edward D. Verrier	20
15	Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study 2006 ·European Heart Journal ·Abhinav Goyal,Kenneth W. Mahaffey,Jyotsna Garg,José Carlos Nicolau,Judith S. Hochman,W. Douglas Weaver,Pierre Théroux,Gustavo B.F. Oliveira,Thomas G. Todaro,Christopher F. Mojcik,Paul W. Armstrong,Christopher B. Granger	135
16	Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery 2006 ·Journal of Thoracic and Cardiovascular Surgery ·M. Carrier,Philippe Menasché,Jerrold H. Levy,Mark F. Newman,KM Taylor,Axel Haverich,(unknown),Stanton K. Shernan,Frans Van de Werf,(unknown),Thomas G. Todaro,Peter X. Adams,Edward D. Verrier	28
17	Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview 2006 ·American Heart Journal ·Kenneth W. Mahaffey,Frans Van de Werf,Stanton K. Shernan,Christopher B. Granger,Edward D. Verrier,Thomas G. Filloon,Thomas G. Todaro,Peter X. Adams,Jerrold H. Levy,Vic Hasselblad,Paul W. Armstrong	30
18	Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention 2005 ·American Heart Journal ·Paul W. Armstrong,Peter X. Adams,Hussein R. Al‐Khalidi,Christian W. Hamm,David R. Holmes,William W. O’Neill,Thomas G. Todaro,Alec Vahanian,Frans Van de Werf,Christopher B. Granger	47
19	810-4 Pexelizumab, a C5 complement inhibitor, reduces 30-day mortality in patients undergoing coronary artery bypass surgery or receiving reperfusion therapy for acute myocardial infarction 2004 ·Journal of the American College of Cardiology ·Frans Van de Werf,Paul W. Armstrong,Jerrold H. Levy,Christopher B. Granger,Robert M. Califf,Peter X. Adams,(unknown),Christopher F. Mojcik,Thomas G. Todaro,(unknown)	1
20	Terminal Complement Blockade With Pexelizumab During Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass 2004 ·JAMA ·Edward D. Verrier,Stanton K. Shernan,Kenneth M. Taylor,Frans Van de Werf,Mark F. Newman,John C. Chen,Michel Carrier,Axel Haverich,Kevin J. Malloy,Peter X. Adams,Thomas G. Todaro,Christopher F. Mojcik,Scott A. Rollins,Jerrold H. Levy,(unknown)	138

About Thomas G. Todaro

Thomas G. Todaro is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (13 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Mechanical Circulatory Support Devices (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (721 citations), Immunology (330 citations) and Emergency Medicine (121 citations). Thomas G. Todaro has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Paul W. Armstrong, Christopher B. Granger, Kenneth W. Mahaffey, Pierre Théroux, Thomas G. Filloon, W. Douglas Weaver, Judith S. Hochman, José Carlos Nicolau, Peter X. Adams and Scott A. Rollins. Their work appears in journals such as JAMA, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact